3DPrint.com April 8, 2025
Chinese pharmaceutical company Triastek gets U.S. green light to test once-a-day anticoagulant pill made with 3D printing. This new kind of blood thinner pill is designed to stay in the stomach longer and is one step closer to reaching patients with atrial fibrillation (AFib), a condition that affects the heart’s rhythm and raises the risk of stroke.
On February 27, 2025, the U.S. Food and Drug Administration (FDA) gave Investigational New Drug (IND) clearance to Triastek to begin clinical trials in the U.S. for a drug called T20G. This means the company can now test the pill in people to evaluate how safe and effective it is.
T20G had already received clearance from Chinese regulators in January 2024, authorizing the...
Today's Sponsors
Today's Sponsor